Utama › Kegagalan Jantung › Florida › Orlando
Kajian klinikal Kegagalan Jantung di Orlando, FL
16 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Mengambil pesertaFasa 3
- Flourish Research, Winter Park · 5 mi jauh
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Mengambil pesertaFasa 1
- Flourish Research, Winter Park · 5 mi jauh
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Mengambil pesertaFasa 3
- Flourish Research, Winter Park · 5 mi jauh
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Mengambil pesertaFasa 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi jauh
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Mengambil pesertaFasa 3
- AdventHealth, Orlando
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi jauh
- dan 1 lagi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Mengambil pesertaFasa 3
- Research Site, Orlando
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Mengambil peserta
- Advent Health, Orlando
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Mengambil peserta
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi jauh
- K2 Medical Research, Maitland · 6 mi jauh
Alleviant ALLAY-HF Study
Mengambil peserta
- Advent Health Orlando, Orlando
Assessment of CCM in HF With Higher Ejection Fraction
Mengambil peserta
- AdventHealth Orlando, Orlando
- Revival Clinical Research, Orlando
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Mengambil pesertaFasa 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi jauh
CCM OPEN HF Registry
Mengambil pesertaKajian pemerhatian
- AdventHealth Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Mengambil peserta
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Mengambil pesertaFasa 3
- AdventHealth, Orlando
Kajian Kegagalan Jantung di bandar lain
- New York City, NY51 kajian
- Boston, MA44 kajian
- Dallas, TX42 kajian
- Houston, TX36 kajian
- Cleveland, OH33 kajian
- Chicago, IL31 kajian
- Philadelphia, PA31 kajian
- San Francisco, CA29 kajian
- St. Louis, MO26 kajian
- Durham, NC26 kajian
- Kansas City, MO25 kajian
- Atlanta, GA25 kajian
Kajian lain di Orlando
- Kanser Paru-paru Bukan Sel Kecil44 kajian
- Obesiti31 kajian
- Kanser Metastatik29 kajian
- Berat Badan Berlebihan27 kajian
- Penyakit Alzheimer25 kajian
- Diabetes Jenis 224 kajian
- Kanser (semua jenis)24 kajian
- Kanser Payudara23 kajian
- Kanser Ovari22 kajian
- Kolitis Ulseratif22 kajian
- Kanser Paru-paru21 kajian
- Kanser Kolorektal19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.